“To improve usability in hospitals, as well as to prevent DNA and RNA contamination in laboratory settings, we need to think not only about inactivating microorganisms and viruses, but about ...
Faron Pharmaceuticals Oy (GB:FARN) has released an update. Faron Pharmaceuticals has filed a patent application for the use of soluble Clever-1 in inactivating T-cells, a development poised to expand ...
TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers and inflammation via novel immunotherapies, today ...
This important study explores the interplay between gene dosage and gene mutations in the evolution of antibiotic resistance. The authors provide solid evidence to connect proteostasis with gene ...
Adding, changing or inactivating PrP genes in normal mice creates genetically engineered mice called transgenic mice. Hamster prions can not infect normal mice but they can infect transgenic mice ...